Literature DB >> 24741095

Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.

Zhiguo Sun1, Bingyi Xiao1, Hem Chandra Jha1, Jie Lu1, Shuvomoy Banerjee1, Erle S Robertson2.   

Abstract

UNLABELLED: Kaposi's sarcoma-associated herpesvirus (KSHV) has a significant contributory role in the development of three major human neoplastic or lymphoproliferative diseases: Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD). These diseases are associated with chromosomal instability, a hallmark of human cancer. The latency-associated nuclear antigen (LANA) encoded by KSHV plays a key role in regulating a number of cellular pathways critical for oncogenesis. KSHV LANA alone can induce the development of B-cell hyperplasia and lymphoma in mice expressing LANA. LANA also induces chromosomal instability, thus promoting oncogenesis. However, the precise mechanism underlying LANA-mediated chromosomal instability remains uncharted. Here we report that LANA promoted the induction of chromosomal instability and the formation of micronuclei and multinucleation through its interaction with one of the critical spindle checkpoint proteins, Bub1, and the resulting degradation of Bub1. This interaction occurs through the Knl and kinase domains of Bub1, identified as important for stability and degradation. These results suggest that LANA can dysregulate Bub1 activity, which leads to aberrant chromosome replication and aneuploidy, thus contributing to KSHV-mediated oncogenesis. IMPORTANCE: This work represents the first set of results identifying a novel mechanism by which LANA, a latency-associated antigen encoded by KSHV, can induce the degradation of Bub1, a spindle checkpoint protein that is important for spindle checkpoint signaling and chromosome segregation. The downregulation of Bub1 mediated by LANA resulted in chromosomal instability, a hallmark of cancer. We further investigated the specific domains of Bub1 that are required for the interaction between LANA and Bub1. The results demonstrated that the Knl and kinase domains of Bub1 are required for the interaction between LANA and Bub1. In addition, we also investigated the mechanism by which LANA promoted Bub1 degradation. Our results showed that LANA interacted physically with the anaphase-promoting complex (APC/C), thus promoting the degradation of Bub1 in a ubiquitin-dependent process.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24741095      PMCID: PMC4054434          DOI: 10.1128/JVI.00554-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Microtubule-dependent changes in assembly of microtubule motor proteins and mitotic spindle checkpoint proteins at PtK1 kinetochores.

Authors:  D B Hoffman; C G Pearson; T J Yen; B J Howell; E D Salmon
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

2.  Timing and checkpoints in the regulation of mitotic progression.

Authors:  Patrick Meraldi; Viji M Draviam; Peter K Sorger
Journal:  Dev Cell       Date:  2004-07       Impact factor: 12.270

Review 3.  Apoptosis and genomic instability.

Authors:  Boris Zhivotovsky; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

4.  Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression.

Authors:  Victoria L Johnson; Maria I F Scott; Sarah V Holt; Deema Hussein; Stephen S Taylor
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

5.  Kinetochore targeting of fission yeast Mad and Bub proteins is essential for spindle checkpoint function but not for all chromosome segregation roles of Bub1p.

Authors:  Vincent Vanoosthuyse; Rebekka Valsdottir; Jean-Paul Javerzat; Kevin G Hardwick
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Transcriptional coactivation of c-Jun by the KSHV-encoded LANA.

Authors:  Jiabin An; Yiping Sun; Matthew B Rettig
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

8.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.

Authors:  Subhash C Verma; Sumit Borah; Erle S Robertson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 9.  The spindle checkpoint, aneuploidy, and cancer.

Authors:  Rajnish Bharadwaj; Hongtao Yu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

10.  Spindle checkpoint proteins and chromosome-microtubule attachment in budding yeast.

Authors:  Emily S Gillett; Christopher W Espelin; Peter K Sorger
Journal:  J Cell Biol       Date:  2004-02-09       Impact factor: 10.539

View more
  14 in total

1.  Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.

Authors:  Zhiguo Sun; Hem Chandra Jha; Yong-Gang Pei; Erle S Robertson
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

2.  A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.

Authors:  Crystal Woodard; Gangling Liao; C Rory Goodwin; Jianfei Hu; Zhi Xie; Thaila F Dos Reis; Rob Newman; Heesool Rho; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

Review 3.  In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Ariana G Bravo Cruz; Blossom Damania
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

4.  Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.

Authors:  Zhiguo Sun; Hem Chandra Jha; Erle S Robertson
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

Review 5.  KSHV LANA--the master regulator of KSHV latency.

Authors:  Timsy Uppal; Sagarika Banerjee; Zhiguo Sun; Subhash C Verma; Erle S Robertson
Journal:  Viruses       Date:  2014-12-11       Impact factor: 5.048

Review 6.  The Modulation of Apoptotic Pathways by Gammaherpesviruses.

Authors:  Shuvomoy Banerjee; Timsy Uppal; Roxanne Strahan; Prerna Dabral; Subhash C Verma
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

Review 7.  The Role of Gammaherpesviruses in Cancer Pathogenesis.

Authors:  Hem Chandra Jha; Shuvomoy Banerjee; Erle S Robertson
Journal:  Pathogens       Date:  2016-02-06

8.  Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells.

Authors:  Moshe Giladi; Rosa S Schneiderman; Tali Voloshin; Yaara Porat; Mijal Munster; Roni Blat; Shay Sherbo; Zeev Bomzon; Noa Urman; Aviran Itzhaki; Shay Cahal; Anna Shteingauz; Aafia Chaudhry; Eilon D Kirson; Uri Weinberg; Yoram Palti
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

9.  GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors.

Authors:  Philipp Jansen; Hansgeorg Müller; Georg C Lodde; Anne Zaremba; Inga Möller; Antje Sucker; Annette Paschen; Stefan Esser; Jörg Schaller; Matthias Gunzer; Fabian Standl; Sebastian Bauer; Dirk Schadendorf; Thomas Mentzel; Eva Hadaschik; Klaus G Griewank
Journal:  Front Genet       Date:  2021-04-30       Impact factor: 4.599

10.  KSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell Proliferation.

Authors:  Hem C Jha; Zhiguo Sun; Santosh K Upadhyay; Darine W El-Naccache; Rajnish K Singh; Sushil K Sahu; Erle S Robertson
Journal:  PLoS Pathog       Date:  2016-07-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.